Combination antiviral and anti-inflammatory therapy mitigates persistent neurological deficits in mice post SARS-CoV-2 infection
Proceedings of the National Academy of Sciences · 13.01.2026 · 123 (2)
DOI: 10.1073/pnas.2530209123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 07.01.2026. Verfasst von Abhishek Kumar Verma und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Iowa, Iowa City, IA 52242. Hauptthemen laut MEDLINE: Antiviral Agents, COVID-19, Anti-Inflammatory Agents, Nervous System Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH | National Institute on Aging (NIA), NINDS NIH HHS, HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS).
Abstract (Originalsprache)
Post-acute sequelae of COVID-19 (PASC) encompasses persistent neurological disease, including olfactory and cognitive dysfunction. The basis for this dysfunction is poorly understood. Here, we report neurological dysfunction for at least 120 d postinfection in mice infected with a virulent nonneurotropic mouse-adapted SARS-CoV-2. Long after recovery from nasal infection, we observed diminished tyrosine hydroxylase expression in olfactory bulb glomeruli and in substantia nigra. Similar changes were observed in brains of COVID-19 deceased patients. Vulnerability of dopaminergic neurons in these brain areas was accompanied by increased proinflammatory cytokines, and neurobehavioral changes. RNAseq analysis unveiled persistent microglia activation, similar to human neurodegenerative diseases. Treatment with antivirals (nirmatrelvir and molnupiravir) at the time of infection minimally prevented neurological abnormalities, consistent with patient data. In contrast, antivirals plus corticosteroids resulted in nearly complete recovery of neurological function. Remarkably, initiation of combined therapy even three days after infection improved outcomes. Together these results demonstrate that neurological dysfunction in SARS-CoV-2 infected mice resembles human neurodegenerative disease and indicate that minimizing inflammation early after SARS-CoV-2 infection may be critical for decreasing neurological PASC. The requirement for decreasing inflammation soon after infection may also explain why antiviral therapy has had inconsistent effects in patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of Iowa, Iowa City, IA 52242.
- Iowa Neuroscience Institute, University of Iowa, Iowa City, IA 52242.
- Department of Neurology, University of Iowa, Iowa City, IA 52242.
- Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN 55455.
- Department of Cell Biology and Physiology, Stowers Institute for Medical Research, Kansas City, MO 64110.
- Department of Pathology, University of Iowa, Iowa City, IA 52242.
ORCID-Profile: Abhishek Kumar Verma, David K Meyerholz, Stanley Perlman
Förderung
- HHS | NIH | National Institute on Aging (NIA)
- NINDS NIH HHS
- HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
- NIAID NIH HHS
- HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases
Zitieren
APA
Verma, A. K., Tan, L., Schuster, N., Moye, S. L., Lin, L. C., Lowery, S., Duraisami, E., Lloréns, J. E. A., Qiu, Q., Hefti, M., Meyerholz, D. K., Coleman, M. C., Yu, C. R., Albers, M. W., & Perlman, S. (2026). Combination antiviral and anti-inflammatory therapy mitigates persistent neurological deficits in mice post SARS-CoV-2 infection. Proceedings of the National Academy of Sciences, 123(2). https://doi.org/10.1073/pnas.2530209123
Vancouver
Verma AK, Tan L, Schuster N, Moye SL, Lin LC, Lowery S, et al. Combination antiviral and anti-inflammatory therapy mitigates persistent neurological deficits in mice post SARS-CoV-2 infection. Proceedings of the National Academy of Sciences. 2026;123(2). doi:10.1073/pnas.2530209123
BibTeX
@article{Verma2026,
author = {Verma, Abhishek Kumar and Tan, Lu and Schuster, Noah and Moye, Skyler L and Lin, Li-Chun and Lowery, Shea and Duraisami, Eazhisaivallabi and Lloréns, Juan E Abrahante and Qiu, Qiang and Hefti, Marco and Meyerholz, David K and Coleman, Mitchell C and Yu, C Ron and Albers, Mark W and Perlman, Stanley},
title = {Combination antiviral and anti-inflammatory therapy mitigates persistent neurological deficits in mice post SARS-CoV-2 infection},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {2},
doi = {10.1073/pnas.2530209123}
}
EUVIMED